There are some data that noninvasive ventilation could be useful in long-term treatment of some patients with COPD. Apart from the information from arterial blood gas analysis, which data should we use to decide which stable hypercapnic patients with COPD will benefit most from NIV? Is there a subgroup of patients in whom this treatment should be routinely used?
Extrapulmonary TB constitutes <6% of all TB cases in Poland. This number is much below the EU average, which is about 22%. What might be the reasons for such a discrepancy, given that the prevalence of TB in Poland is about 18/100,000 and is significantly higher than in most EU countries? Could this mean that many cases of extrapulmonary TB are underdiagnosed in Poland?
A recently published paper discussed the use of CT as an initial study in patients presenting with suspected community-acquired pneumonia. The results were encouraging but not game-changing. When could a clinician consider CT in an outpatient presenting with symptoms of CAP?
What treatment would you recommend in a patient with idiopathic pulmonary fibrosis who cannot be treated with nintedanib or pirfenidone?
Should chest X-rays still be used for lung cancer screening?
Should the management of patients with small lung nodules be individually tailored to particular regions or countries?
Are advances in PET/CT likely to change our approach to patients with solitary pulmonary nodules?
What should be the role of pulmonary medicine specialists in the diagnostic workup of patients with solitary pulmonary nodules?
Can we treat peak expiratory flow (PEF) measurement as the sole parameter confirming the diagnosis of asthma?
Should nitric oxide be used in the diagnostic workup of patients with asthma-COPD overlap syndrome?
English
Polski
Español
українська